The Administrator announces that the Potentially Erroneous Data Parameter for all CME CF Cryptocurrency Pricing Product indices will be amended on June 11th, 2024, at approximately 11:00 London Time.
The future parameter levels for each index are summarised in the table below.

Any questions or queries should be directed to [email protected].
Any user wishing to file a complaint regarding these changes can do so confidentially by writing to [email protected].
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
High-beta large-cap digital assets mostly extended gains over the recent week, with LINK up 11.6%. Mega caps benefited less though, with BTC +1.9% and ETH actually dipping 0.9%. Still, volatility cooled: BVXS implied vol. index was -5.21, and front-end funding eased sharply: BTC SIRB fell 260 bps.

CF Benchmarks
The CFB xStocks Product Suite delivers regulated real-time indices and a standardized corporate actions data feed- so venues can build on xStocks without building the infrastructure first. Watch our shorty video to find out more.

CF Benchmarks
Size extended its multi-week dominance as the market rallied 4.3% to start May. Value posted its best week in over a month, a notable shift amid ongoing DeFi TVL dislocation following the Kelp DAO exploit. Momentum and growth lagged.

Mark Pilipczuk
By clicking Accept, you consent to CF Benchmarks's use of cookies.
Visit Cookie Settings to learn how CF Benchmarks uses cookies and to adjust your preferences.